Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

Europe - EPA:ICAD - FR0000035081 - REIT

21.12 EUR
0 (0%)
Last: 10/31/2025, 7:00:00 PM
Fundamental Rating

3

ICAD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 39 industry peers in the Diversified REITs industry. ICAD may be in some trouble as it scores bad on both profitability and health. ICAD is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ICAD had positive earnings in the past year.
In the past year ICAD had a positive cash flow from operations.
In multiple years ICAD reported negative net income over the last 5 years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.85%, ICAD is doing worse than 80.00% of the companies in the same industry.
ICAD's Return On Equity of -4.79% is on the low side compared to the rest of the industry. ICAD is outperformed by 80.00% of its industry peers.
With a Return On Invested Capital value of 2.76%, ICAD is not doing good in the industry: 72.50% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ICAD is in line with the industry average of 3.49%.
The 3 year average ROIC (2.14%) for ICAD is below the current ROIC(2.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

ICAD's Operating Margin of 19.60% is on the low side compared to the rest of the industry. ICAD is outperformed by 80.00% of its industry peers.
In the last couple of years the Operating Margin of ICAD has declined.
The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICAD is destroying value.
The number of shares outstanding for ICAD remains at a similar level compared to 1 year ago.
ICAD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ICAD is higher compared to a year ago.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.64. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.64, ICAD is doing worse than 60.00% of the companies in the same industry.
The Debt to FCF ratio of ICAD is 45.49, which is on the high side as it means it would take ICAD, 45.49 years of fcf income to pay off all of its debts.
ICAD has a worse Debt to FCF ratio (45.49) than 77.50% of its industry peers.
ICAD has a Debt/Equity ratio of 0.97. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
ICAD has a worse Debt to Equity ratio (0.97) than 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Altman-Z 0.64
ROIC/WACC0.96
WACC2.86%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.06 indicates that ICAD should not have too much problems paying its short term obligations.
ICAD has a Current ratio of 1.06. This is in the better half of the industry: ICAD outperforms 80.00% of its industry peers.
ICAD has a Quick Ratio of 1.06. This is a bad value and indicates that ICAD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.81, ICAD is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1

3. Growth

3.1 Past

The earnings per share for ICAD have decreased strongly by -72.25% in the last year.
Measured over the past years, ICAD shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.69% on average per year.
The Revenue for ICAD has decreased by -13.82% in the past year. This is quite bad
ICAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.64% yearly.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

The Earnings Per Share is expected to decrease by -1.60% on average over the next years.
Based on estimates for the next years, ICAD will show a decrease in Revenue. The Revenue will decrease by -1.36% on average per year.
EPS Next Y10.6%
EPS Next 2Y2.29%
EPS Next 3Y-1.6%
EPS Next 5YN/A
Revenue Next Year-6.62%
Revenue Next 2Y-1.93%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.09, the valuation of ICAD can be described as very cheap.
95.00% of the companies in the same industry are more expensive than ICAD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.11. ICAD is valued rather cheaply when compared to this.
ICAD is valuated cheaply with a Price/Forward Earnings ratio of 6.39.
ICAD's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 95.00% of the companies in the same industry.
ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.55.
Industry RankSector Rank
PE 7.09
Fwd PE 6.39
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 92.50% of the companies listed in the same industry.
ICAD's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ICAD is more expensive than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.66
EV/EBITDA 10.51
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y2.29%
EPS Next 3Y-1.6%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.49%, ICAD is a good candidate for dividend investing.
ICAD's Dividend Yield is comparable with the industry average which is at 5.95.
Compared to an average S&P500 Dividend Yield of 2.37, ICAD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.49%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-185.46%
EPS Next 2Y2.29%
EPS Next 3Y-1.6%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (10/31/2025, 7:00:00 PM)

21.12

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16/amc
Inst Owners73.36%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.61B
Revenue(TTM)1.50B
Net Income(TTM)-187100000
Analysts69.47
Price Target24.9 (17.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.49%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-185.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.19%
PT rev (3m)-2.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE 7.09
Fwd PE 6.39
P/S 1.07
P/FCF 15.66
P/OCF 4.9
P/B 0.41
P/tB 0.42
EV/EBITDA 10.51
EPS(TTM)2.98
EY14.11%
EPS(NY)3.31
Fwd EY15.65%
FCF(TTM)1.35
FCFY6.39%
OCF(TTM)4.31
OCFY20.4%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.67
PEG (5Y)N/A
Graham Number58.58
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.86%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Debt/EBITDA 9.41
Cap/Depr 211.04%
Cap/Sales 15.05%
Interest Coverage 4.1
Cash Conversion 81.96%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.86%
ROIC/WACC0.96
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y10.6%
EPS Next 2Y2.29%
EPS Next 3Y-1.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-6.62%
Revenue Next 2Y-1.93%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year51.07%
EBIT Next 3Y14.51%
EBIT Next 5Y8.67%
FCF growth 1Y240.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.57%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%

ICADE / ICAD.PA FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status for ICAD stock?

ChartMill assigns a valuation rating of 7 / 10 to ICADE (ICAD.PA). This can be considered as Undervalued.


Can you provide the profitability details for ICADE?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of ICADE (ICAD.PA) stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 7.09 and the Price/Book (PB) ratio is 0.41.


Can you provide the dividend sustainability for ICAD stock?

The dividend rating of ICADE (ICAD.PA) is 4 / 10 and the dividend payout ratio is -185.46%.